Additionally, extra-hepatic driver mechanisms of insulin resistance-mediated steatosis have been suggested, such as impairment of insulin-mediated suppression of lipolysis in white adipose tissue or insulin resistance in skeletal muscle [50]. The gene discussed is INS; the disease is steatosis.